By Amy Banks
This incredible recognition celebrates the innovation, dedication, and teamwork that define Magstim, from research and engineering to clinical and customer support. Together, we’re driving progress in neuroscience and mental health technology, continually pushing the boundaries of what’s possible. Advancing Mental Health and Neuroscience At Magstim, we’re proud to be a global leader in non-invasive … Continued
By Amy Banks
A New Option for Chronic Pain Relief Chronic pain affects millions, limiting mobility, emotional wellbeing, and quality of life. Traditional treatments such as medication, injections, or surgery don’t always provide effective results. Now there’s a new solution: the New Magstim Rapid, recently FDA-cleared, MDR, UKCA approved for chronic pain treatment.* Non-Invasive, Drug-Free Pain Therapy … Continued
By Amy Banks
Welcony Introduces the Next Evolution in TMS Research – The New Magstim Rapid TMS System Innovation never stands still at Magstim, and neither should your research or TMS therapy. That’s why Magstim, a Welcony brand is proud to announce the release of the New Magstim Rapid TMS System. The new Magstim Rapid represents a significant … Continued
By Amy Banks
Seeing the Brain Like Never Before: A New Vision for Brain Research. Introducing the EGI GES 500 When the James Webb Space Telescope revealed its first images, the world experienced a rare moment: the ability to see the universe with clarity and depth never before possible. For brain researchers, EGI’s new Geodesic EEG System 500 … Continued
By Amy Banks
Magstim Passes Compliance with Strict European Union Medical Device Regulations Expanding Magstim Access to Entire EU Marketplace CARMARTHENSHIRE, United Kingdom – (MAY 16, 2025) – Magstim has been granted EU MDR Certification for all transcranial magnetic stimulation (TMS) systems, demonstrating compliance with strict European Union Medical Device Regulations. This provides a path for Magstim TMS … Continued
By Amy Banks
Magstim gains FDA Clearance for TMS Treatment in U.S. Adolescent Patients Magstim Horizon Inspire and 3.0 Transcranial Magnetic Stimulation Systems have received FDA clearance for the treatment of Major Depressive Disorder (MDD) in adolescent patients, ages 15-21. This represents a major advancement in mental health care, introducing new opportunities for effective, non-invasive treatments designed specifically for younger patients struggling with … Continued
By Amy Banks
Exciting Magstim News – Magstim TMS Cited in Science Robotics In the latest edition of Science Robotics (January 2025), the study, “Surmounting the Ceiling Effect of Motor Expertise by Novel Sensory Experience with a Hand Exoskeleton”, highlights research using a Magstim 2002 Transcranial Magnetic Stimulation (TMS) stimulator whilst enhancing the neural adaptability of participants as they interacted with a state-of-the-art hand … Continued
By Amy Banks
By Amy Banks